|
"ou da liang"的相關文件
顯示項目 1-10 / 33 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-05-12T07:39:41Z |
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
|
Hsieh, Ching-Hung; Jian, Cheng-Zhe; LIANG-IN LIN; Low, Guan-Sian; Ou, Ping-Yun; CHIUN HSU; Ou, Da-Liang |
| 臺大學術典藏 |
2022-05-12T07:37:59Z |
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma
|
Shao, Yu-Yun; Chen, Pai-Sheng; LIANG-IN LIN; Lee, Bin-Shyun; Ling, Andrew; Cheng, Ann-Lii; CHIUN HSU; Ou, Da-Liang |
| 臺大學術典藏 |
2022-05-12T07:34:04Z |
Deciphering the Role of Pyrvinium Pamoate in the Generation of Integrated Stress Response and Modulation of Mitochondrial Function in Myeloid Leukemia Cells through Transcriptome Analysis
|
Fu, Yu-Hsuan; Tseng, Chi-Yang; Lu, Jeng-Wei; Lu, Wen-Hui; Lan, Pei-Qi; Chen, Chien-Yuan; Ou, Da-Liang; LIANG-IN LIN |
| 臺大學術典藏 |
2022-01-25T06:01:28Z |
Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias
|
Su, Kuan-Wei; Ou, Da-Liang; Fu, Yu-Hsuan; HWEI-FANG TIEN; Hou, Hsin-An; Lin, Liang-In |
| 臺大學術典藏 |
2022-01-25T05:59:47Z |
Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation
|
Fu, Yu-Hsuan; Ou, Da-Liang; Yang, Yi-Ru; Su, Kuan-Wei; Chen, Chien-Yuan; HWEI-FANG TIEN; Lai, Zheng-Sheng; Shen, Che-Kun James; Chien, Hsiung-Fei; Lin, Liang-In |
| 臺大學術典藏 |
2021-07-06T01:54:58Z |
Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation
|
Fu, Yu-Hsuan; Ou, Da-Liang; Yang, Yi-Ru; Su, Kuan-Wei; Tien, Hwei-Fan; Lai, Zheng-Sheng; Shen, Che-Kun James; Chien, Hsiung-Fei; Chen, Chien-Yuan; LIANG-IN LIN |
| 臺大學術典藏 |
2021-07-06T01:53:04Z |
Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias
|
Su, Kuan-Wei; Ou, Da-Liang; Fu, Yu-Hsuan; Tien, Hwei-Fang; Hou, Hsin-An; LIANG-IN LIN |
| 臺大學術典藏 |
2020-08-14T01:27:01Z |
Development of a PD-L1-Expressing Orthotopic Liver Cancer Model: Implications for Immunotherapy for Hepatocellular Carcinoma
|
Ou, Da-Liang;Lin, Yu-Yang;Hsu, Chia-Lang;Lin, Yin-Yao;Chen, Chia-Wei;Yu, Jhang-Sian;Shi-Chuen Miaw;Hsu, Ping-Ning;Cheng, Ann-Lii;Chiun Hsu; Ou, Da-Liang; Lin, Yu-Yang; Hsu, Chia-Lang; Lin, Yin-Yao; Chen, Chia-Wei; Yu, Jhang-Sian; SHI-CHUEN MIAW; Hsu, Ping-Ning; Cheng, Ann-Lii; Chiun Hsu |
| 臺大學術典藏 |
2020-06-29T23:55:12Z |
Mouse Models for Immunotherapy in Hepatocellular Carcinoma
|
OU, DA-LIANG |
| 臺大學術典藏 |
2020-06-29T23:38:10Z |
TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma
|
Lai, Hui-Huang; Li, Chih-Wei; Hong, Chih-Chen; Sun, Hung-Yu; Chiu, Ching-Feng; Ou, Da-Liang; Chen, Pai-Sheng |
顯示項目 1-10 / 33 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
